CLINICAL TRIAL OF A NEW ANTI-BRADYKININ, ANTI-INFLAMMATORY DRUG, KETOPROFEN (19.583 R.P.) IN MIGRAINE PROPHYLAXIS

Authors

  • PER STENSRUD M.D.,

  • OTTAR SJAASTAD M.D.


Ancillary